Literature DB >> 16842881

Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg.

Jung-Bin Kim1, Joon Sig Choi, Kihoon Nam, Minhyung Lee, Jong-Sang Park, Ja-Kyeong Lee.   

Abstract

PAMAM-Arg is a cationic arginine-grafted polyamidoamine (PAMAM) dendrimer. In the previous study, we reported that PAMAM-Arg facilitates transfection in a range of mammalian cell types. In the present study, we investigated the transfection efficiency of PAMAM-Arg in primary cortical cultures, which are known to be extremely vulnerable to exogenous gene transfection. PAMAM-Arg/DNA complexes showed particularly high transfection efficiencies and low cytotoxicity in primary cortical cells, as compared to other gene carriers such as, native PAMAM, polyethylenimine (BPEI), and Lipofectamine. Efficient transfection was not limited to neurons but extended to all three glial cells, astrocytes, microglia, and oligodendrocytes, present in these primary cortical cultures. The potential use of PAMAM-Arg was demonstrated by efficient gene knock-down by transfecting HMGB1 shRNA-expressing plasmid. The numbers of green fluorescent protein (GFP)-positive and HMGB1-negative cells indicated that PAMAM-Arg/shRNA-expressing plasmid complex suppressed target gene expression in over 40% of cells, which is the highest level achieved to date in primary cortical culture by any gene carrier. Here, we present evidence of the successful delivery and expression of both a reporter gene and of a shRNA-expressing plasmid in primary cortical cells, which demonstrates the potential of PAMAM-Arg for mediating gene delivery to primary neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842881     DOI: 10.1016/j.jconrel.2006.05.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

1.  Astrocytic responses to DNA delivery using nucleofection.

Authors:  H Muyderman; W P Yew; B Homkajorn; N R Sims
Journal:  Neurochem Res       Date:  2010-08-21       Impact factor: 3.996

2.  Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro.

Authors:  Olga Igoucheva; Aislinn Kelly; Jouni Uitto; Vitali Alexeev
Journal:  J Invest Dermatol       Date:  2007-12-13       Impact factor: 8.551

3.  Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency.

Authors:  Hui Wang; Hai-Bo Shi; Shan-Kai Yin
Journal:  Exp Ther Med       Date:  2011-06-27       Impact factor: 2.447

Review 4.  Non-viral gene therapy for spinal cord regeneration.

Authors:  Li Yao; Sheng Yao; William Daly; William Hendry; Anthony Windebank; Abhay Pandit
Journal:  Drug Discov Today       Date:  2012-05-24       Impact factor: 7.851

Review 5.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147

Review 6.  Handling of iron oxide and silver nanoparticles by astrocytes.

Authors:  Michaela C Hohnholt; Mark Geppert; Eva M Luther; Charlotte Petters; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-12-06       Impact factor: 3.996

7.  Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.

Authors:  A M O'Mahony; B M D C Godinho; J Ogier; M Devocelle; R Darcy; J F Cryan; C M O'Driscoll
Journal:  ACS Chem Neurosci       Date:  2012-08-03       Impact factor: 4.418

Review 8.  Drug delivery systems for the treatment of ischemic stroke.

Authors:  Taiyoun Rhim; Dong Yun Lee; Minhyung Lee
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

9.  In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.

Authors:  Aoife M O'Mahony; Stephane Desgranges; Julien Ogier; Aoife Quinlan; Marc Devocelle; Raphael Darcy; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2012-11-29       Impact factor: 4.200

10.  Highly efficient transfection of rat cortical neurons using carbosilane dendrimers unveils a neuroprotective role for HIF-1alpha in early chemical hypoxia-mediated neurotoxicity.

Authors:  Inmaculada Posadas; Beatriz López-Hernández; Maria Isabel Clemente; Jose Luis Jiménez; Paula Ortega; Javier de la Mata; Rafael Gómez; María Angeles Muñoz-Fernández; Valentín Ceña
Journal:  Pharm Res       Date:  2009-02-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.